Cornerstone Planning Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Cornerstone Planning Group’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$341	Buy	+1,000	New	+$299	﹤0.01%	1486

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Planning Group's CEMI Position: Q4 2022 in Review

Cornerstone Planning Group opened a new position in Chembio diagnostics, Inc. (CEMI) in Q4 2022: 1,000 shares worth $341. The stake represents ﹤0.01% of the portfolio and ranks #1486 among its holdings.

38 funds tracked by Wall St. Rank hold CEMI as of Q4 2022.

Cornerstone Planning Group held 1,000 shares of Chembio diagnostics, Inc. worth $341 as of Q4 2022.
Chembio diagnostics, Inc. was a new Cornerstone Planning Group position in Q4 2022.
Chembio diagnostics, Inc. made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q4 2022, its #1486 holding.
38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2022.

Based on Cornerstone Planning Group's 13F filing for Q4 2022, filed 14 Feb 2023.